bullish

Mural Oncology Plc (MURA) - Tuesday, Dec 26, 2023

363 Views26 Mar 2024 18:52
Syndicated
SUMMARY
  • MURA is a micro-cap, speculative, pre-revenue, and non-compounder company that spun off from Alkermes
  • Despite a rough start, it is gaining attention and has a market cap of $74 million with $16/share in cash
  • Morgan Stanley projects a trading value range estimate of $32-$63/share based on potential sales from their lead pipeline candidate; company is funded with $275 million in cash until 2025

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x